BCH Order Code BAP1Z BAP1-Tumor Predisposition Syndrome, BAP1 Full Gene Analysis, Varies
Ordering Guidance
For a comprehensive hereditary renal cancer gene panel, consider RENCP / Hereditary Renal Cancer Panel, Varies, which tests 19 genes including BAP1.
Testing for BAP1 gene as part of a customized panel is available. For more information see CGPH / Custom Gene Panel, Hereditary, Next-Generation Sequencing, Varies.
Targeted testing for familial variants (also called site-specific or known mutations testing) is available for this gene. For more information see FMTT / Familial Mutation, Targeted Testing, Varies.
Shipping Instructions
Specimen preferred to arrive within 96 hours of collection.
Specimen Required
Patient Preparation: A previous bone marrow transplant from an allogenic donor will interfere with testing. Call 800-533-1710 for instructions for testing patients who have received a bone marrow transplant.
Specimen Type: Whole blood
Container/Tube:
Preferred: Lavender top (EDTA) or yellow top (ACD)
Acceptable: Any anticoagulant
Specimen Volume: 3 mL
Collection Instructions:
1. Invert several times to mix blood. Do not aliquot.
2. Send specimen in original tube.
Specimen Stability Information: Ambient (preferred) 4 days/Refrigerated
Forms
1. New York Clients-Informed consent is required. Document on the request form or electronic order that a copy is on file
-Informed Consent for Genetic Testing (T576)
-Informed Consent for Genetic Testing (Spanish) (T826)
2. Molecular Genetics: Inherited Cancer Syndromes Patient Information Sheet (T519)
3. If not ordering electronically, complete, print, and send a Oncology Test Request (T729) with the specimen.
Useful For
Evaluation of patients with a personal or family history suggestive of BAP1-tumor predisposition syndrome (BAP1-TPDS)
Establishing a diagnosis of BAP1-TPDS allowing for targeted cancer surveillance based on associated risks
Identifying genetic variants associated with increased risk for BAP1-TPDS, allowing for predictive testing and appropriate screening of at-risk family members
Special Instructions
Method Name
Sequence Capture and Targeted Next-Generation Sequencing followed by Polymerase Chain Reaction (PCR) and Sanger Sequencing
Reporting Name
BAP1 Full Gene AnalysisSpecimen Type
VariesSpecimen Minimum Volume
See Specimen Required
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Varies | Varies |
Reference Values
An interpretive report will be provided.
Day(s) Performed
Varies
Report Available
3 to 4 weeksPerforming Laboratory

Test Classification
This test was developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
81479
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
BAP1Z | BAP1 Full Gene Analysis | In Process |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
614623 | Test Description | 62364-5 |
614624 | Specimen | 31208-2 |
614625 | Source | 31208-2 |
614626 | Result Summary | 50397-9 |
614627 | Result | 82939-0 |
614628 | Interpretation | 69047-9 |
614629 | Resources | 99622-3 |
614630 | Additional Information | 48767-8 |
614631 | Method | 85069-3 |
614632 | Genes Analyzed | 48018-6 |
614633 | Disclaimer | 62364-5 |
614634 | Released By | 18771-6 |